Flare Therapeutics
Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets for transcription factor regulation to address mutations that cause disease. Its drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Flare Therapeutics use?+
Flare Therapeutics uses 18 technologies including AOS, Google Analytics, Google Tag Manager.
What industry is Flare Therapeutics in?+
Flare Therapeutics operates in the Biopharma industry.
Where is Flare Therapeutics based?+
Flare Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026